logo

Actiwhey based microencapsulation solution for sustainable food manufacturing

Sector: Hospital • Location: Finland

Source: EU Funding & Tenders Portal

Project
Ended

Overuse of antibiotics in meat production causes human antimicrobial resistance, diseases and gut related disorders, leading to 1.2m life-threatening hospital infections and 19,000 deaths from MRSA-bacteria each year. The best solution is sustainable antibiotic free food production, improved food safety and nutrition value, wider use of probiotics and increased functional foods production. Compani

Project Information FAQ

Project Information

3 Q
The project “Actiwhey based microencapsulation solution for sustainable food manufacturing” is an infrastructure initiative in the Hospital sector, located in Finland. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Want to explore the full details? View the full report

Participants

Sponsoring Agency

Obfuscated Data

Company

Obfuscated Data

Status

Original status

ended

Taiyo status

Obfuscated Data

Taiyo last update

00-00-0000

Available timestamps

00-00-0000

Available timestamp type

Obfuscated Data

Contact

Contact name

Obfuscated Data

Phone

0000000000

Email

ObfuscatedData@email.com

Address

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description

Overuse of antibiotics in meat production causes human antimicrobial resistance, diseases and gut related disorders, leading to 1.2m life-threatening hospital infections and 19,000 deaths from MRSA-bacteria each year. The best solution is sustainable antibiotic free food production, improved food safety and nutrition value, wider use of probiotics and increased functional foods production. Companies like Bon Appétit, Tyson Foods, Smithfield, McDonalds, etc. are voluntarily banning antibiotics treated food products. To meet this trend and EU regulations, new cost-effective technologies for processing delicate substances and active ingredients are needed in EU. Uniq Bioresearch has developed and patented ACTIWHEY® microencapsulation technology that addresses these challenges and provides market leading nutritional efficiency; extended shelf-life, increased food safety and countless new opportunities for food, feed and nutraceuticals manufacturers. ACTICAPS project aims to 1) reduce the microencapsulation costs by 91%; 2) achieve 70% fill-coating ratio; 3) improve controlled release and other key advantages; 4) set up pilot production for market validation and dissemination; 5) create a scale-up package, incl. process planning strategy, production manuals and licencing concept; 6) validate the innovation in 3 market segments with most potential for fast market uptake. This project is an integral part of our long-term development roadmap. Our market uptake potential is based on 11+ years of R&D and business success; established key customer base; validated patented technology, experienced team and detailed feasibility study for identifying the best business and commercialisation strategy. We target a high growth €7.3b market and expect to generate sales revenue of €38m and create more than 50 new jobs by 2022. Besides current customer base, we have received potential order indications from market-leading feed and food producers like Hankkija, Raisio, Valio etc.

Original sub-sector

Obfuscated

Original Currency

USD

Original budget

000000000000000

Procurement method

Obfuscated Data

Budget

000000000000000

Location

Region

Obfuscated

Country

Obfuscated

State

Obfuscated Data

County

Obfuscated

Location

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability

High

Data quality score

100%

Source

Obfuscated Data

URL

obfuscated_data,obfuscateddata.com

More Details

Project Type

Obfuscated Data

Article Published Date

Obfuscated Data